The ebstein’s anomaly market is projected to grow from USD 16.2 billion in 2025 to USD 35.0 billion by 2035, at a CAGR of 8.0%. Surgical Treatment will dominate with a 63.1% market share, while echocardiogram will lead the diagnosis segment with a 28.4% share.